Media talk about Inversago Pharma

MONTREAL (CANADA) – September 28, 2020 – The Globe & Mail, BioteCanada’s Insights magazine and Endpoints News recently published articles about Inversago Pharma.

The Globe & Mail – Investors bet $35-million on Montreal startup’s effort to revive failed class of weight-loss drugs by Sean Silcoff

Insights Magazine – Fall 2020, Pages 80-81 – The Peripheral CB1 Company in Four Key Figures

Endpoint News – Upstart sets off on a clinical journey, looking to make a name for its 2nd-gen CB1 blockers by John Carroll